182 related articles for article (PubMed ID: 29037662)
1. Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
Ward M; Norman H; D'Souza MS
Behav Brain Res; 2018 Feb; 338():56-65. PubMed ID: 29037662
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activation of kappa opioid receptors in the nucleus accumbens core and ventral tegmental area increases the aversive effects of nicotine.
Pham H; Seeley SL; D'Souza MS
Behav Pharmacol; 2022 Jun; 33(4):266-281. PubMed ID: 35256559
[TBL] [Abstract][Full Text] [Related]
3. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
Kelsey JE; Verhaak AM; Schierberl KC
Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
5. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
6. Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.
Walker BM; Kissler JL
Neuropsychopharmacology; 2013 Oct; 38(11):2278-85. PubMed ID: 23689673
[TBL] [Abstract][Full Text] [Related]
7. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
[TBL] [Abstract][Full Text] [Related]
8. Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.
Grella SL; Funk D; Coen K; Li Z; Lê AD
Behav Brain Res; 2014 May; 265():188-97. PubMed ID: 24583188
[TBL] [Abstract][Full Text] [Related]
9. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.
Tejeda HA; Natividad LA; Orfila JE; Torres OV; O'Dell LE
Psychopharmacology (Berl); 2012 Nov; 224(2):289-301. PubMed ID: 22659976
[TBL] [Abstract][Full Text] [Related]
11. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.
Sante AB; Nobre MJ; Brandão ML
Behav Pharmacol; 2000 Nov; 11(7-8):583-9. PubMed ID: 11198129
[TBL] [Abstract][Full Text] [Related]
12. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.
Bals-Kubik R; Herz A; Shippenberg TS
Psychopharmacology (Berl); 1989; 98(2):203-6. PubMed ID: 2569217
[TBL] [Abstract][Full Text] [Related]
14. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
Ko MC; Willmont KJ; Lee H; Flory GS; Woods JH
Brain Res; 2003 Aug; 982(1):38-44. PubMed ID: 12915238
[TBL] [Abstract][Full Text] [Related]
15. The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats.
Funk D; Coen K; Lê AD
Brain Behav; 2014 May; 4(3):356-67. PubMed ID: 24944865
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H.
Mori T; Yoshizawa K; Nomura M; Isotani K; Torigoe K; Tsukiyama Y; Narita M; Suzuki T
Addict Biol; 2012 Jul; 17(4):717-24. PubMed ID: 21392175
[TBL] [Abstract][Full Text] [Related]
17. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
[TBL] [Abstract][Full Text] [Related]
18. The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety.
Marco EM; Llorente R; Pérez-Alvarez L; Moreno E; Guaza C; Viveros MP
Behav Brain Res; 2005 Sep; 163(2):212-8. PubMed ID: 15979169
[TBL] [Abstract][Full Text] [Related]
19. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
[TBL] [Abstract][Full Text] [Related]
20. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
Raffa RB; Baron DA; Tallarida RJ
Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
